Thermo Fisher Scientific

 


Principal Investigator: Hubert Schach, PhD, Director Business Development Autoimmunity

Description: Thermo Fisher Scientific (former Phadia) is a diagnostic company which develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. Phadia has direct representation in 22 markets through wholly owned market companies and through distributors in many countries around the world. The corporate headquarters are located in Uppsala, Sweden.

Interests of centre leader:

– Novel disease markers for early RA identification, prognosis and therapy
response
– Validation of new markers with clinically characterised patient samples
– Development of in-vitro assays on multiplex and single plex platforms

Role in consortium:

– To provide a platform for multiple analysis of antibody specificities using a high-throughput,
low volume technology

– To provide pre-developed assays for clinical evaluation of clinical cohorts for known
autoantibodies specificities